PL371682A1 - Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG) - Google Patents

Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG)

Info

Publication number
PL371682A1
PL371682A1 PL03371682A PL37168203A PL371682A1 PL 371682 A1 PL371682 A1 PL 371682A1 PL 03371682 A PL03371682 A PL 03371682A PL 37168203 A PL37168203 A PL 37168203A PL 371682 A1 PL371682 A1 PL 371682A1
Authority
PL
Poland
Prior art keywords
fdg
fluor
deoxy
glucose
solution
Prior art date
Application number
PL03371682A
Other languages
English (en)
Inventor
Petrus Simon Kruijer
Hector Humberto Knight
Original Assignee
Mallinckrodt Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc. filed Critical Mallinckrodt Inc.
Publication of PL371682A1 publication Critical patent/PL371682A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL03371682A 2002-04-24 2003-04-23 Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG) PL371682A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02076638A EP1356827A1 (en) 2002-04-24 2002-04-24 Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution

Publications (1)

Publication Number Publication Date
PL371682A1 true PL371682A1 (pl) 2005-06-27

Family

ID=28685968

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371682A PL371682A1 (pl) 2002-04-24 2003-04-23 Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG)

Country Status (13)

Country Link
US (1) US8182788B2 (pl)
EP (2) EP1356827A1 (pl)
JP (2) JP5132869B2 (pl)
KR (1) KR20050005456A (pl)
CN (1) CN1323724C (pl)
AT (1) ATE422903T1 (pl)
AU (1) AU2003225124B2 (pl)
CA (1) CA2483181C (pl)
DE (1) DE60326220D1 (pl)
IL (2) IL164805A0 (pl)
NO (1) NO329160B1 (pl)
PL (1) PL371682A1 (pl)
WO (1) WO2003090789A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
US20080193379A1 (en) * 2005-06-14 2008-08-14 Nihon Medi-Physics Co., Ltd. Radioactive Diagnostic Imaging Agent
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
KR20090025282A (ko) * 2006-06-21 2009-03-10 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
EP2029182A2 (en) 2006-06-21 2009-03-04 GE Healthcare AS Stabilisation of radiopharmaceutical precursors
JPWO2008056481A1 (ja) * 2006-11-09 2010-02-25 日本メジフィジックス株式会社 放射性画像診断剤
RU2445120C2 (ru) 2006-12-21 2012-03-20 Нихон Меди-Физикс Ко., Лтд. Радиоактивный агент для диагностической визуализации
US8343459B2 (en) 2007-02-13 2013-01-01 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
TW200918102A (en) * 2007-10-24 2009-05-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
CA2704172A1 (en) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
JPWO2009057577A1 (ja) * 2007-10-30 2011-03-10 日本メジフィジックス株式会社 新規アミロイド親和性化合物の使用及び製造方法
EP2214722A1 (en) * 2007-11-07 2010-08-11 GE Healthcare BV Stabilization of radiopharmaceuticals
EP2419096B1 (en) 2009-04-15 2019-11-13 Lantheus Medical Imaging, Inc. Stabilization of radiopharmaceutical compositions using ascorbic acid
WO2012021882A2 (en) * 2010-08-13 2012-02-16 Siemens Medical Solutions Usa, Inc. Formulation, apparatus and method for stabilizing radiopharmaceuticals
DK2658831T3 (en) 2010-12-29 2017-04-24 Ge Healthcare Ltd elution
US20130005958A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US20130004414A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US20150231249A1 (en) * 2011-12-21 2015-08-20 Ge Healthcare Limited 18f-fluciclovine compositions in citrate buffers
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
FR3054445B1 (fr) * 2016-07-26 2019-07-05 Laboratoires Cyclopharma Synthese d'une composition d'agent radioactif
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
GB202005282D0 (en) * 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
SE9002117L (sv) * 1990-06-14 1991-08-26 Nils Elander Mikrovaagsanordning foer behandling av precessvaetskor
JP3370666B2 (ja) 1990-07-06 2003-01-27 マリンクロッド・インコーポレイテッド 放射性レニウム錯体溶液の調製法
JPH0797340A (ja) * 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
BE1010280A3 (fr) * 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
AU736481C (en) * 1996-10-07 2002-06-06 Du Pont Pharmaceuticals Company Radiopharmaceuticals for imaging infection and inflammation

Also Published As

Publication number Publication date
WO2003090789A1 (en) 2003-11-06
EP1496946B1 (en) 2009-02-18
US8182788B2 (en) 2012-05-22
EP1356827A1 (en) 2003-10-29
AU2003225124A1 (en) 2003-11-10
US20050175536A1 (en) 2005-08-11
JP2006500319A (ja) 2006-01-05
EP1496946A1 (en) 2005-01-19
KR20050005456A (ko) 2005-01-13
JP2010248244A (ja) 2010-11-04
IL164805A0 (en) 2005-12-18
JP5132869B2 (ja) 2013-01-30
DE60326220D1 (de) 2009-04-02
CA2483181C (en) 2011-06-28
CN1323724C (zh) 2007-07-04
ATE422903T1 (de) 2009-03-15
NO20045070L (no) 2004-11-22
NO329160B1 (no) 2010-08-30
CA2483181A1 (en) 2003-11-06
AU2003225124B2 (en) 2007-06-14
IL164805A (en) 2009-06-15
CN1646175A (zh) 2005-07-27

Similar Documents

Publication Publication Date Title
IL164805A0 (en) Method for obtaining a2-18f-fluor-2-deoxy-d-glucose(18f-fdg)-solution
WO2007014110A3 (en) Method and system for evaluating delivered dose
BRPI0307702B8 (pt) formulações de solução contendo anticorpo
GB2411990B (en) Improved architecture for generating intermediate representations for program code conversion
WO2006092800A3 (en) System and method for scanning an intraoral cavity
WO2007010534A3 (en) Imaging protocols
EP3537217A3 (en) Positive resist composition, resin used for the positive resist composition, compound used for synthesis of the resin and pattern forming method using the positive resist composition
IL158650A0 (en) Polysiloxane, process for production thereof and radiation-sensitive resin composition
EP1829936A4 (en) ACTIALLY HARDENABLE COMPOSITION, ACTIALLY HARDENABLE INK AND IMAGING METHOD
ATE539698T1 (de) Zahnärztliches implantatsystem
WO2008133108A1 (ja) エポキシシリコーン及びその製造方法、並びに、それを用いた硬化性樹脂組成物とその用途
DE60028600D1 (de) Uv-härtbare zusammensetzungen
CA2585802A1 (en) Industrial process for the preparation of 17-hydroxy-6.beta.,7.beta.;15.beta.,16.beta.-bismethylene-3-oxo-17.alpha.pregn-4-ene-21-carboxylic acid.gamma.-lactone and key-intermediates for this process
AU2003294361A8 (en) Selectively locking device
DE502006000814D1 (de) Medizinisches, insbesondere dentalmedizinisches Handstück
ATE323095T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
WO2002019108A3 (en) Method for providing bitwise constraints for test generation
WO2007017794A3 (en) Skin-treatment device
ES2103623T3 (es) Procedimiento de obtencion de zeolitas que contienen titanio.
UA86775C2 (ru) Способ очистки раствора альфа-1-антитрипсина
NL1025709A1 (nl) 3-(1-[3-(1,3-Benzothiazol-6-yI)propylcarbamoyl]cycloalkyI)propaanzuurderivaten Derivatives als NEP-remmers.
DE50306947D1 (de) Sequenzgestell
ITMI20022185A1 (it) Processo per la preparazione di fenolo mediante idrodeossigenazione di benzendioli.
ATE332902T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
GB2382393B (en) Fastening element

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed